Jordan2020-02-04T23:51:08+00:00Thursday 16 Jan| AgilVax Announces Expansion of Series A-1 Financing testing
Jordan2019-11-19T13:44:05+00:00Monday 18 Nov| AgilVax to Present Positive Preclinical Data for Monoclonal Antibody Targeting xCT at the American Association for Cancer Research’s Tumor Immunology and Immunotherapy Conference testing
Jordan2019-11-07T21:28:10+00:00Thursday 7 Nov| AgilVax to Present at the 2019 NYC Oncology Investor Conference testing
Jordan2019-07-25T12:11:01+00:00Thursday 25 Jul| AgilVax Appoints Dr. Joseph Patti as Chief Executive Officer testing
Jordan2019-05-29T15:13:16+00:00Wednesday 29 May| AgilVax Triggers $2 Million Phase II Fast Track SBIR Grant and Initiates GMP Manufacturing testing
Jordan2019-04-29T19:59:32+00:00Wednesday 9 Jan| AgilVax Elects Dr. David T. Hung, Former Founder and CEO of Medivation, to Its Board of Directors testing
